Statins associate with better clinical outcomes in chronic hepatitis B patients with HBsAg seroclearance

ConclusionPatients with HBsAg seroclearance have favorable long-term survival. However, liver-related adverse outcomes still develop, necessitating further investigations on beneficial effects of statins.
Source: Hepatology International - Category: Infectious Diseases Source Type: research